SEC 13F Intelligence

Moody Lynn Lieberson & Walker, LLC / ABT

Moody Lynn Lieberson & Walker, LLC’s Abbott Laboratories Position

Does Moody Lynn Lieberson & Walker, LLC own Abbott Laboratories (ABT)? Yes — 206.6K shares worth $21M (+1.19% of its 13F portfolio) as of Q1 2026, down from 269.8K shares the prior filed quarter.

Position Value
$21M
Q1 2026
Shares
206.6K
% of Portfolio
+1.19%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $23MQ4 ’18Q1 ’19: $21MQ2 ’19: $22MQ3 ’19: $27MQ4 ’19: $28MQ4 ’19Q1 ’20: $20MQ2 ’20: $23MQ3 ’20: $28MQ4 ’20: $28MQ4 ’20Q1 ’21: $30MQ2 ’21: $26MQ3 ’21: $26MQ4 ’21: $37MQ4 ’21Q1 ’22: $27MQ2 ’22: $25MQ3 ’22: $21MQ4 ’22: $23,580Q4 ’22Q1 ’23: $21MQ2 ’23: $23MQ3 ’23: $20MQ4 ’23: $24MQ4 ’23Q1 ’24: $27MQ2 ’24: $25MQ3 ’24: $27MQ4 ’24: $27MQ4 ’24Q1 ’25: $37MQ2 ’25: $36MQ3 ’25: $35MQ4 ’25: $34MQ4 ’25Q1 ’26: $21Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026206.6K$21M+1.19%
Q4 2025269.8K$34M+1.79%
Q3 2025263.5K$35M+1.90%
Q2 2025267.5K$36M+2.10%
Q1 2025279.8K$37M+2.38%
Q4 2024240.9K$27M+1.67%
Q3 2024235.1K$27M+1.65%
Q2 2024238.1K$25M+1.62%
Q1 2024240.5K$27M+1.84%
Q4 2023215.9K$24M+1.81%
Q3 2023211.2K$20M+1.75%
Q2 2023209.5K$23M+1.84%
Q1 2023205.4K$21M+1.87%
Q4 2022214.8K$23,580+2.16%
Q3 2022217.0K$21M+2.03%
Q2 2022227.5K$25M+2.22%
Q1 2022228.2K$27M+1.98%
Q4 2021262.6K$37M+2.48%
Q3 2021221.4K$26M+1.96%
Q2 2021225.1K$26M+1.97%
Q1 2021253.3K$30M+2.52%
Q4 2020254.9K$28M+2.40%
Q3 2020255.2K$28M+2.75%
Q2 2020253.3K$23M+2.52%
Q1 2020257.5K$20M+2.79%
Q4 2019319.4K$28M+2.68%
Q3 2019318.4K$27M+2.97%
Q2 2019256.4K$22M+2.37%
Q1 2019260.3K$21M+2.38%
Q4 2018318.3K$23M+3.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Moody Lynn Lieberson & Walker, LLC’s full portfolio or all institutional holders of ABT.